Skip to main content

Military Health System

Army Announces FDA Clearance of Field Deployable TBI Blood Test

Image of Military personnel standing in the snow preparing to fire a missile . Soldiers from 1st/120th Field Artillery, Wisconsin National Guard, prepare to fire a M-777 Howitzer during Winter Strike 21 at Camp Grayling Maneuver Center, Michigan in Jan. 2021. Soon the Army should have a field-deployable means to detect and evaluate soldiers for TBI (Photo by: Air National Guard photo by Master Sgt. Dan Heaton).

Recommended Content:

Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence | Brain Injury Awareness To Improve Readiness | Brain Injury Awareness To Improve Readiness | Brain Injury Awareness To Improve Readiness | Brain Injury Awareness To Improve Readiness | Traumatic Brain Injury Center of Excellence | Brain Injury Awareness To Improve Readiness

The U.S. Army Medical Materiel Development Activity, in partnership with Abbott, announced the U.S. Food and Drug Administration approval of the Abbott i-STAT™ Alinity™ Traumatic Brain Injury plasma assay, a rapid blood test for TBI in January.

Between 2000 and 2019, more than 400,000 service members experienced a TBI as a result of combat injuries and training accidents, as well as everyday activities such as sporting events.

Developing a field-deployable solution for the detection and evaluation of TBI among our wounded service members serving at home and deployed overseas has been a top priority for the Department of Defense for more than a decade.

"A rapid test for TBI is a critical addition to our downrange capability to care for the brain health of our most important weapon system, the Warfighter, and help maintain a high state of readiness across the Force," said Army Brig. Gen. Michael Talley, commanding general for the U.S. Army Medical Research and Development Command and Fort Detrick, Maryland.

The i-STAT Alinity TBI plasma assay can identify two brain-specific protein markers that rapidly appear in the blood following a TBI. This blood test will provide medical professionals with objective markers that indicate injury to the brain, as opposed to relying on subjective descriptions of the injury-causing incident, reduce the need for head Computed Tomography scans.

"A blood-based biomarker laboratory assay (blood test) for TBI will greatly enhance the ability of DOD medical personnel to objectively assess Service Members who have suffered a suspected TBI. The ability to avoid unnecessary evacuations for head CT scans could really impact the efficiency of TBI management,” said Dr. Krista Caudle, product manager for USAMMDA's Warfighter Brain Health Project Management Office.

The goal for initial implementation of the laboratory assay is to assist with the management of patients with a suspected TBI, particularly focusing on the areas where Service Members would be required to be evacuated from the operational setting to obtain a CT scan of the head. The overall objective is to have a logistically suitable, whole-blood, point-of-care TBI biomarker test with rapid turnaround time.

"The laboratory assay for TBI product development program is an example of how USAMRDC and private industry can share a common vision and achieve a common goal. Over the years, the program progressed through basic science studies at Walter Reed Army Institute of Research and USAMRDC's Combat Casualty Care Research Program, then into product development and clinical trials in USAMMDA, and ultimately U.S. FDA clearance," said Caudle.

The FDA-approved Banyan Biomarkers, Inc., Brain Trauma Indicator™, also funded by USAMMDA, laid the groundwork and served as a foundation for the i-STAT Alinity TBI plasma assay. The DOD partnered with Abbott to develop the TBI biomarkers into a field-deployable laboratory platform, which is an easy-to-use TBI cartridge utilized in the i-STAT Alinity device, the new version of the i-STAT 1 that is currently fielded by the U.S. Army. Recent user assessments have established preliminary suitability of the assay and device in operational laboratory settings for the Army. Future testing will confirm system suitability and enable fielding of this capability.

The laboratory assay for TBI point-of-care biomarker effort has been funded by the U.S. Army and is managed by USAMMDA's Warfighter Brain Health Project Management Office.

You also may be interested in...

Head Injury and Dizziness Fact Sheet

Fact Sheet
7/30/2020

This TBICoE fact sheet can be used to educate patients with concussion/mild TBI on how to manage dizziness related to their injury.

Recommended Content:

Traumatic Brain Injury Center of Excellence | Patient and Family Resources | TBI Provider Resources | TBI Educators | Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence | Centers of Excellence

Chronic Traumatic Encephalopathy (CTE) Frequently Asked Questions

Fact Sheet
7/30/2020

This fact sheet provides answers and information to commonly asked questions about chronic traumatic encephalopathy, or CTE.

Recommended Content:

Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence | Patient and Family Resources

Concussion/mTBI and PTSD Fact Sheet

Fact Sheet
7/30/2020

This fact sheet defines concussion/mild traumatic brain injury and posttraumatic stress disorder and explains how overlapping symptoms often occur. It also describes why it’s important to seek out treatment for both conditions and provides helpful advice on what to tell your family and friends to help in the recovery process.

Recommended Content:

Traumatic Brain Injury Center of Excellence | Posttraumatic Stress Disorder | Patient and Family Resources | Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence | TBICoE Research

Headaches Following Concussion/mTBI Fact Sheet

Fact Sheet
7/30/2020

Although each headache is different, identifying common causes, or triggers, is important for health care providers and patients to determine appropriate treatment. This fact sheet provides non-drug options to help those diagnosed with a mild TBI and associated post-traumatic headache manage symptoms.

Recommended Content:

Traumatic Brain Injury Center of Excellence | Patient and Family Resources | TBI Educators | TBI Provider Resources

Cognitive Rehabilitation Following Mild to Moderate TBI Clinical Recommendation - Short

Publication
7/30/2020

This short version of the Cognitive Rehabilitation Following Mild to Moderate TBI Clinical Recommendation provides an at-a-glance overview of the full-length version for quick access and use on the job.

Recommended Content:

Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence | SCORE Study Manuals | Traumatic Brain Injury Center of Excellence

Cognitive Rehabilitation for Following Mild to Moderate TBI Clinical Recommendation - Full

Publication
7/30/2020

This TBI clinical recommendation is broken down into three primary categories: Modifications for Service Members and Veterans; Interventions and Strategies to Address Cognitive Dysfunction; and, Delivery of Rehabilitation for Patients with Cognitive Challenges. Each category contains clinical recommendations, the background and rationale behind them, evidence review references, and clinical resources.

Recommended Content:

Traumatic Brain Injury Center of Excellence | TBI Provider Resources | TBI Educators | Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence

Cognitive Rehabilitation Following Mild to Moderate TBI Clinical Recommendation Appendices

Publication
7/30/2020

The appendices to the Cognitive Rehabilitation Following Mild to Moderate TBI Clinical Recommendation include a glossary of terms, outcome measures, evidence tables, and other useful resources.

Recommended Content:

Traumatic Brain Injury Center of Excellence | TBI Provider Resources | TBICoE Research | TBICoE Research Studies

Military Acute Concussion Evaluation 2 (MACE 2)

Publication
7/30/2020

The 2018 Military Acute Concussion Evaluation 2 (MACE 2) is an acute assessment tool for all medically trained personnel who treat service members involved in a potentially concussive event. The MACE 2 incorporates current state-of-the-science traumatic brain injury information, including vestibular-ocular-motor screening. The MACE 2 is an update to and replaces the original MACE.

Recommended Content:

Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence | TBI Provider Resources | TBI Educators | Traumatic Brain Injury Center of Excellence

Cognitive Rehabilitation Following Mild to Moderate TBI - Referring Provider Resource

Publication
7/30/2020

This resource answers common questions that referring providers may have, such as how to determine if a patient is having cognitive difficulties or whether the patient is a good candidate for cognitive rehabilitation following a mild to moderate traumatic brain injury.

Recommended Content:

Traumatic Brain Injury Center of Excellence | TBI Provider Resources | TBI Educators | TBICoE Research | Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence

Recurrent Concussion Evaluation

Publication
7/30/2020

The TBICoE Recurrent Concussion Evaluation card is designed to guide providers in the management of patients with a history of three or more documented concussions within a 12-month span.

Recommended Content:

Traumatic Brain Injury Center of Excellence | TBI Provider Resources | Traumatic Brain Injury Center of Excellence | Traumatic Brain Injury Center of Excellence

DVBIC eye-tracking tech may help service members with concussions

Article
7/28/2020
Soldier sitting in front of a laptop with headphones on

The Fusion technology is more objective, by assessing eye reaction time.

Recommended Content:

Traumatic Brain Injury Center of Excellence

The Language of Anger and Depression Among Patients with Concussions

Article
6/4/2020
Image of naval captain talking to another military person

Soldiers often do not overtly express their feelings of depression.

Recommended Content:

Traumatic Brain Injury Center of Excellence | Posttraumatic Stress Disorder | Anger | Depression

Warm Handoff for Transitioning Servicemembers Suffering from PTSD and TBI

Congressional Testimony
7/8/2019

S. 2987, SASC Report for FY 2019, 115-262, Pg. 203-204

Recommended Content:

Posttraumatic Stress Disorder | Traumatic Brain Injury Center of Excellence

Chronic Traumatic Encephalopathy (CTE)

Congressional Testimony
6/13/2019

H.R. 5515 HASC Report for FY 2019 115-676, Pg. 128

Recommended Content:

Traumatic Brain Injury Center of Excellence

Traumatic Brain Injury/Psychological Health

Congressional Testimony
1/25/2019

S. 3000, SAC Report for FY 2017, 114-263, Pg. 193

Recommended Content:

Traumatic Brain Injury Center of Excellence |
<< < ... 11 12 13 14 15  ... > >> 
Showing results 211 - 225 Page 15 of 19
Refine your search
Last Updated: September 01, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery